NATF strives to bring you the most relevant information in the field of thrombosis research and cardiovascular-related illnesses, which includes topics on thrombosis, stroke prevention, atrial fibrillation, and acute coronary syndrome.

PERT: A New Model of Care

When Mark went to the hospital, he had never heard of a pulmonary embolism (PE). But at 49 years old,…

A Look at Lymphedema

Lymphedema is a serious health issue that many people live with, yet it is often misunderstood. Lymphedema develops when lymph…

A DOAC Deep Dive: Dabigatran

For the past several decades, warfarin has been the go-to anticoagulant drug for doctors, but now new treatments have emerged…

Research Report: One Brave Idea

Research Report: One Brave Idea Heart disease kills over 600,000 people in the United States every year, accounting for 1…

EINSTEIN CHOICE Trial

Recent trial results from the EINSTEIN CHOICE study, published in the New England Journal of Medicine and presented at the…

The DAWN Trial

At the 3rd annual European Stroke Organization Conference the results of the DAWN Trial were presented. The results suggest that…

The Power of Statins

Statins are a class of drug that is traditionally used to treat high cholesterol. They work by blocking an enzyme…